Zobrazeno 1 - 3
of 3
pro vyhledávání: '"MRS Oliveira"'
Autor:
CNM Breviglieri, RG Vasconcelos, CN Santos, VC Ginani, MRS Oliveira, ABW Batalha, JF Marques, GS Alencar, A Seber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S688- (2024)
Pediatric Acute Myeloid Leukemia (AML) presents significant treatment challenges, particularly post-transplant relapses. The use of the only specific immunotherapy for AML may increase transplant-related toxicities due to the calicheamicin. This scar
Externí odkaz:
https://doaj.org/article/e55c74ee82c8490bb7e7420f999c4f65
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S686- (2024)
Chimeric antigen receptor (CAR) T-cell therapy is a choice for ALL relapsed post-HCT but is hindered by cost and the required lengthy washout period, emphasizing the need for new strategies to prevent relapse. For those at high relapse risk due to di
Externí odkaz:
https://doaj.org/article/74d8ff45a74541df89beedfbca6a21b1
Autor:
CNM Breviglieri, CN Santos, RG Vasconcelos, VC Ginani, ABW Batalha, MRS Oliveira, GS Alencar, JF Marques, A Seber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S688-S689 (2024)
Relapsed Acute Lymphoblastic Leukemia (ALL) post-hematopoietic stem cell transplantation (HCT) have very poor outcomes. Patients face increased toxicity and poorer responses to therapy. With limited access to Chimeric Antigen Receptor (CAR) T-cell th
Externí odkaz:
https://doaj.org/article/dde0e2390c9542799a4ba743309d9af4